论文部分内容阅读
丙型肝炎病毒(HCV)是输血后肝炎的主要病原,目前血液筛查所采用的第3代丙肝总抗体酶联免疫吸附试剂(ELISA)仍有较长的“窗口期”[1],无法完全避免HCV的经血传播。军事医学科学院基础医学研究所研制的HCV分片段酶联免疫确认试剂盒具有灵敏度高、特异性强、早期诊断的优点[2],我?
Hepatitis C virus (HCV) is the major cause of post-transfusion hepatitis and there is still a long “window” of the third-generation total hepatitis C virus antibody (ELISA) used in blood screening [1] Completely prevent the spread of HCV blood. The HCV Fragment ELISA Kit developed by the Institute of Basic Medical Sciences of the Academy of Military Medical Sciences has the advantages of high sensitivity, high specificity and early diagnosis [2]